[1]
|
G. Pappas, et al., "Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity," Cancer Gene Ther, vol. 14, pp. 543-9, Jun 2007.
|
[2]
|
H. Jin, et al., "Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) mice," Cancer Gene Ther, vol. 15, pp. 275-83, May 2008.
|
[3]
|
C. Ren, et al., "Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model," Stem Cells, vol. 26, pp. 2332-8, Sep 2008.
|
[4]
|
S. Kidd, et al., "Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment," Cytotherapy, vol. 12, pp. 615-25, Sep 2010.
|
[5]
|
K. Nakamura, et al., "Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model," Gene Ther, vol. 11, pp. 1155-64, Jul 2004.
|
[6]
|
S. Gunnarsson, et al., "Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma," J Neuroimmunol, vol. 218, pp. 140-4, Jan 25 2010.
|
[7]
|
X. Chen, et al., "A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs," Mol Ther, vol. 16, pp. 749-56, Apr 2008.
|
[8]
|
I. T. Cavarretta, et al., "Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth," Mol Ther, vol. 18, pp. 223-31, Jan 2010.
|
[9]
|
H. Miletic, et al., "Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene," Mol Ther, vol. 15, pp. 1373-81, Jul 2007.
|
[10]
|
G. Xu, et al., "Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats," Cell Biol Int, vol. 33, pp. 466-74, Apr 2009.
|
[11]
|
M. Kanehira, et al., "Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells," Cancer Gene Ther, vol. 14, pp. 894-903, Nov 2007.
|
[12]
|
L. G. Menon, et al., "Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy," Stem Cells, vol. 27, pp. 2320-30, Sep 2009.
|
[13]
|
M. R. Loebinger, et al., "Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer," Cancer Res, vol. 69, pp. 4134-42, May 15 2009.
|
[14]
|
X. Y. Sun, et al., "MSC(TRAIL)-mediated HepG2 cell death in direct and indirect co-cultures," Anticancer Res, vol. 31, pp. 3705-12, Nov 2011.
|
[15]
|
X. Y. Sun, et al., "Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine," World J Stem Cells, vol. 3, pp. 96-103, Nov 26 2011.
|
[16]
|
P. A. Steck, et al., "Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers," Nat Genet, vol. 15, pp. 356-62, Apr 1997.
|
[17]
|
J. Li, et al., "PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer," Science, vol. 275, pp. 1943-7, Mar 28 1997.
|
[18]
|
M. Peyrou, et al., "PTEN in liver diseases and cancer," World J Gastroenterol, vol. 16, pp. 4627-33, Oct 7 2010.
|
[19]
|
G. Pappas, et al., "Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity," Cancer Gene Ther, vol. 14, pp. 543-9, Jun 2007.
|
[20]
|
H. Jin, et al., "Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) mice," Cancer Gene Ther, vol. 15, pp. 275-83, May 2008.
|
[21]
|
L. J. Dai, et al., "Potential implications of mesenchymal stem cells in cancer therapy," Cancer Lett, vol. 305, pp. 8-20, Jun 1 2011.
|